Francis Medical today announced the first commercial procedure using its Vanquish water vapor ablation system. Minneapolis-based Francis Medical received FDA clearance for the prostate tissue ablation system in December 2025. Vanquish uses phase shift energy stored in sterile water vapor to convectively transfer thermal energy to cancerous … [Read more...] about Francis Medical reports first commercial cases with Vanquish system
Francis Medical
Francis Medical wins FDA nod for water vapor ablation system
Francis Medical has received FDA clearance for its Vanquish water vapor ablation system for prostate tissue ablation. Maple Grove, Minnesota–based Francis Medical, a privately-held company, announced the 510(k) clearance on Dec. 2, describing it as a critical milestone that enables the commercial launch of the system as a prostate cancer treatment … [Read more...] about Francis Medical wins FDA nod for water vapor ablation system
Francis Medical raises $80M Series C for water vapor ablation tech
Francis Medical announced today that it completed an oversubscribed $80 million Series C equity financing. Arboretum Ventures and Solas BioVentures co-led the Series C round. New investors Orlando Health Ventures and two additional strategic partners also joined in the round. Existing investors Coloplast A/S and Tonkawa participated, … [Read more...] about Francis Medical raises $80M Series C for water vapor ablation tech
